Effect of antiviral therapy in patients with low HBV DNA level on transarterial chemoembolization for hepatocellular carcinoma.

MLA

Kim, Myung Pyo, et al. “Effect of Antiviral Therapy in Patients with Low HBV DNA Level on Transarterial Chemoembolization for Hepatocellular Carcinoma.” Journal of Viral Hepatitis, vol. 28, no. 7, July 2021, pp. 1011–18. EBSCOhost, https://doi.org/10.1111/jvh.13508.

APA

Kim, M. P., Yang, J. K., Jun, B. G., Kim, Y. D., Cheon, G. J., Jung, H. J., Yoo, J.-J., Kim, S. G., Kim, Y. S., Jeong, S. W., Jang, J. Y., Kim, H. S., & Lee, S. H. (2021). Effect of antiviral therapy in patients with low HBV DNA level on transarterial chemoembolization for hepatocellular carcinoma. Journal of Viral Hepatitis, 28(7), 1011–1018. https://doi.org/10.1111/jvh.13508

Chicago

Kim, Myung Pyo, Jae Kook Yang, Baek Gyu Jun, Young Don Kim, Gab Jin Cheon, Hee Jae Jung, Jeong-Ju Yoo, et al. 2021. “Effect of Antiviral Therapy in Patients with Low HBV DNA Level on Transarterial Chemoembolization for Hepatocellular Carcinoma.” Journal of Viral Hepatitis 28 (7): 1011–18. doi:10.1111/jvh.13508.